STOCK TITAN

NewcelX Ltd. (NCEL) Form 4 Filings

NCEL NASDAQ

Ticker history: NLSP became NCEL (NewcelX Ltd.) on . Earlier news and filings retain their original names and dates. View NLSP history.

Here are the Form 4 insider transactions from NewcelX Ltd. (NCEL) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow NCEL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NCEL filings page.

Rhea-AI Summary

NewcelX Ltd. director Samuel Olivier reported open-market purchases of both common shares and warrants. He bought 81,818 common shares of NewcelX at $2.75 per share, with each share sold together with a warrant according to the footnote.

Olivier also acquired 114,545 warrants, each exercisable at $3.025 per common share and expiring on April 27, 2031. Following these transactions, he directly holds 81,818 common shares and 114,545 warrants, reflecting a net addition of 196,363 share-equivalents to his position.

Rhea-AI Summary

NewcelX Ltd. CSO and Director Revel Michel reported open-market purchases of common shares and warrants. He bought 54,545 common shares at $2.75 per share and acquired 76,363 warrants, each giving the right to buy one common share at $3.025.

The filing states the combined purchase price for one common share and one accompanying warrant was $2.75. Following these transactions, Michel directly holds 957,530 common shares, alongside 76,363 warrants expiring on April 27, 2031.